Aug 5 |
Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
|
Jul 31 |
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
|
Jun 27 |
Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
|
Jun 24 |
Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
|
Jun 14 |
Rezolute dips 19%, prices $60M offering at $4 per share
|
Jun 14 |
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
|
Jun 14 |
RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session
|
Jun 14 |
Biggest stock movers today: ADBE, RH, and more
|
Jun 14 |
Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
|
Jun 13 |
Rezolute announces proposed public offering of common stock and pre-funded warrants
|